Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

266 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (A-SMART).
Bryant JM, Palm RF, Herrera R, Rubens M, Hoffe SE, Kim DW, Kaiser A, Ucar A, Fleming J, De Zarraga F, Hodul P, Aparo S, Asbun H, Malafa M, Jimenez R, Denbo J, Frakes JM, Chuong MD. Bryant JM, et al. Among authors: ucar a. Cancer Control. 2023 Jan-Dec;30:10732748221150228. doi: 10.1177/10732748221150228. Cancer Control. 2023. PMID: 36598464 Free PMC article.
Induction Chemotherapy and Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy for Inoperable Pancreas Cancer.
Chuong MD, Herrera R, Kaiser A, Rubens M, Romaguera T, Alvarez D, Kotecha R, Hall MD, McCulloch J, Ucar A, DeZarraga F, Aparo S, Joseph S, Asbun H, Jimenez R, Narayanan G, Gutierrez AN, Mittauer KE. Chuong MD, et al. Among authors: ucar a. Front Oncol. 2022 Jun 23;12:888462. doi: 10.3389/fonc.2022.888462. eCollection 2022. Front Oncol. 2022. PMID: 35814383 Free PMC article.
Causes of Death Among Patients With Initially Inoperable Pancreas Cancer After Induction Chemotherapy and Ablative 5-fraction Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy.
Chuong MD, Herrera R, Ucar A, Aparo S, De Zarraga F, Asbun H, Jimenez R, Asbun D, Narayanan G, Joseph S, Kotecha R, Hall MD, Mittauer KM, Alvarez D, McCulloch J, Romaguera T, Gutierrez A, Kaiser A. Chuong MD, et al. Among authors: ucar a. Adv Radiat Oncol. 2022 Sep 25;8(1):101084. doi: 10.1016/j.adro.2022.101084. eCollection 2023 Jan-Feb. Adv Radiat Oncol. 2022. PMID: 36483070 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 34700495
Phase I trial of low dose N-phosphonacetyl-L-aspartic acid and high dose 5-fluorouracil administered concomitantly with radiation therapy for unresectable localized adenocarcinoma of the pancreas.
Ardalan B, Ucar A, Reddy R, Livingstone AS, Markoe A, Schwade J, Richman SP, Donofrio K. Ardalan B, et al. Among authors: ucar a. Cancer. 1994 Oct 1;74(7):1869-73. doi: 10.1002/1097-0142(19941001)74:7<1869::aid-cncr2820740707>3.0.co;2-j. Cancer. 1994. PMID: 8082092 Clinical Trial.
Clinical spectrum of HTLV-I in south Florida.
Harrington WJ Jr, Ucar A, Gill P, Snodgrass S, Sheremata W, Cabral L, Rabin M, Byrne GE Jr, Berger J, Voight W, et al. Harrington WJ Jr, et al. Among authors: ucar a. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 15;8(5):466-73. doi: 10.1097/00042560-199504120-00006. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7697443
A Randomized, Phase II Trial of Cetuximab With or Without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients With Metastatic Colorectal Carcinoma.
Bowles DW, Kochenderfer M, Cohn A, Sideris L, Nguyen N, Cline-Burkhardt V, Schnadig I, Choi M, Nabell L, Chaudhry A, Ruxer R, Ucar A, Hausman D, Walker L, Spira A, Jimeno A. Bowles DW, et al. Among authors: ucar a. Clin Colorectal Cancer. 2016 Dec;15(4):337-344.e2. doi: 10.1016/j.clcc.2016.03.004. Epub 2016 Mar 31. Clin Colorectal Cancer. 2016. PMID: 27118441 Clinical Trial.
266 results